Compare Divis Laboratories with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES NATCO PHARMA DIVIS LABORATORIES/
NATCO PHARMA
 
P/E (TTM) x 61.3 58.9 104.2% View Chart
P/BV x 14.1 3.7 383.1% View Chart
Dividend Yield % 0.4 0.6 63.9%  

Financials

 DIVIS LABORATORIES   NATCO PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-21
NATCO PHARMA
Mar-21
DIVIS LABORATORIES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs3,913995 393.2%   
Low Rs1,824492 370.8%   
Sales per share (Unadj.) Rs262.5112.5 233.3%  
Earnings per share (Unadj.) Rs74.724.3 308.1%  
Cash flow per share (Unadj.) Rs84.430.7 275.1%  
Dividends per share (Unadj.) Rs20.005.25 381.0%  
Avg Dividend yield %0.70.7 98.7%  
Book value per share (Unadj.) Rs350.1225.1 155.6%  
Shares outstanding (eoy) m265.47182.34 145.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x10.96.6 165.4%   
Avg P/E ratio x38.430.6 125.2%  
P/CF ratio (eoy) x34.024.2 140.3%  
Price / Book Value ratio x8.23.3 248.0%  
Dividend payout %26.821.6 123.7%   
Avg Mkt Cap Rs m761,517135,564 561.7%   
No. of employees `000NANA-   
Total wages/salary Rs m8,2584,149 199.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m69,69420,521 339.6%  
Other income Rs m6271,036 60.5%   
Total revenues Rs m70,32121,557 326.2%   
Gross profit Rs m28,6116,062 472.0%  
Depreciation Rs m2,5561,169 218.6%   
Interest Rs m21133 15.8%   
Profit before tax Rs m26,6605,796 460.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8181,372 496.9%   
Profit after tax Rs m19,8434,424 448.5%  
Gross profit margin %41.129.5 139.0%  
Effective tax rate %25.623.7 108.0%   
Net profit margin %28.521.6 132.1%  
BALANCE SHEET DATA
Current assets Rs m67,90623,373 290.5%   
Current liabilities Rs m17,2845,256 328.8%   
Net working cap to sales %72.688.3 82.3%  
Current ratio x3.94.4 88.4%  
Inventory Days Days1063 15.2%  
Debtors Days Days87873 1,195.5%  
Net fixed assets Rs m45,96324,546 187.3%   
Share capital Rs m531365 145.5%   
"Free" reserves Rs m92,41540,676 227.2%   
Net worth Rs m92,94641,041 226.5%   
Long term debt Rs m09 0.0%   
Total assets Rs m113,86947,919 237.6%  
Interest coverage x1,270.544.6 2,850.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.4 142.9%   
Return on assets %17.49.5 183.4%  
Return on equity %21.310.8 198.1%  
Return on capital %28.714.4 198.8%  
Exports to sales %00-   
Imports to sales %010.9 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA2,231 0.0%   
Fx inflow Rs m011,194 0.0%   
Fx outflow Rs m02,231 0.0%   
Net fx Rs m08,963 0.0%   
CASH FLOW
From Operations Rs m19,4692,988 651.6%  
From Investments Rs m751-1,033 -72.7%  
From Financial Activity Rs m-349-1,857 18.8%  
Net Cashflow Rs m19,87260 33,119.5%  

Share Holding

Indian Promoters % 52.0 48.9 106.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.1 30.3 122.3%  
FIIs % 20.7 12.5 165.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 51.1 94.0%  
Shareholders   223,403 88,439 252.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CAPLIN POINT  BHARAT PARENTALS  SEQUENT SCIENTIFIC  GODAVARI DRU  BETA DRUGS   



Today's Market

SGX Nifty Up 148 Points; Indicates Gap-Up Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a positive note today. At 8:10 am, it was trading up by 148 points, or 1% higher at 17,180 levels.

Related Views on News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

NATCO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 18, 2021 | Updated on Oct 18, 2021

Here's an analysis of the annual report of NATCO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of NATCO PHARMA. Also includes updates on the valuation of NATCO PHARMA.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Nov 26, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 5-YR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS